相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Re-epithelialization and immune cell behaviour in an ex vivo human skin model
Ana Rakita et al.
SCIENTIFIC REPORTS (2020)
Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma
Luis Arnes et al.
GUT (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Andecaliximab/GS-5745 Alone and Combined with mFOLFOX6 in Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Results from a Phase I Study
Manish A. Shah et al.
CLINICAL CANCER RESEARCH (2018)
EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration
Nicole M. Aiello et al.
DEVELOPMENTAL CELL (2018)
Neutrophil Extracellular Traps Participate in All Different Types of Thrombotic and Haemorrhagic Complications of Coronary Atherosclerosis
Kartika R. Pertiwi et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Protease-activated receptor-1 impedes prostate and intestinal tumor progression in mice
G. N. Adams et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
PAR1 signaling on tumor cells limits tumor growth by maintaining a mesenchymal phenotype in pancreatic cancer
Cansu Tekin et al.
Oncotarget (2018)
The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer
Kazuya Kuwada et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies
Aleksandra Adamska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Targeting PAR1: Now What?
Robert Flaumenhaft et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Metalloproteinase-9 contributes to endothelial dysfunction in atherosclerosis via protease activated receptor-1
Jon M. Florence et al.
PLOS ONE (2017)
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
Andrew J. Aguirre et al.
CANCER CELL (2017)
Macrophages and pancreatic ductal adenocarcinoma
Aida Habtezion et al.
CANCER LETTERS (2016)
Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer
Jian Wang et al.
CLINICAL CANCER RESEARCH (2016)
Expressions of Matrix Metalloproteinases 2, 7, and 9 in Carcinogenesis of Pancreatic Ductal Adenocarcinoma
Katarzyna Jakubowska et al.
DISEASE MARKERS (2016)
M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide
Marie Genin et al.
BMC CANCER (2015)
Protease-activated receptors (PARs)-biology and role in cancer invasion and metastasis
Marek Z. Wojtukiewicz et al.
CANCER AND METASTASIS REVIEWS (2015)
Cancers with Higher Density of Tumor-Associated Macrophages Were Associated with Poor Survival Rates
Kyong Yeun Jung et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2015)
A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer Metastasis
Shicheng Su et al.
CANCER CELL (2014)
Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma
Qing-Min Fan et al.
CANCER LETTERS (2014)
Protease-activated receptor-1 drives pancreatic cancer progression and chemoresistance
Karla C. S. Queiroz et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling
Katia Nones et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase
N. Weizman et al.
ONCOGENE (2014)
M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway
Chao-Ying Liu et al.
LABORATORY INVESTIGATION (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46
Laurent O. Mosnier et al.
BLOOD (2012)
β-Adrenergic Receptor Stimulation Transactivates Protease-Activated Receptor 1 via Matrix Metalloproteinase 13 in Cardiac Cells
Fabrice Jaffre et al.
CIRCULATION (2012)
Cooperation of protease-activated receptor 1 and integrin αvβ5 in thrombin-mediated lung cancer cell invasion
Lingyun Zhu et al.
ONCOLOGY REPORTS (2012)
Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
Qiong-wen Zhang et al.
PLOS ONE (2012)
Targeting Protease-Activated Receptor-1 with Cell-Penetrating Pepducins in Lung Cancer
Jaroslaw Cisowski et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Macrophages in cancer and infectious diseases: the 'good' and the 'bad'
Chiara Porta et al.
IMMUNOTHERAPY (2011)
Clinical Significance of the Measurements of Serum Matrix Metalloproteinase-9 and Its Inhibitor (Tissue Inhibitor of Metalloproteinase-1) in Patients With Pancreatic Cancer Metalloproteinase-9 as an Independent Prognostic Factor
Barbara Mroczko et al.
PANCREAS (2009)
PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells
A Boire et al.
CELL (2005)
Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples
S Grisaru-Granovsky et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
分享论文
